Cargando…

Vagal Nerve Activity Predicts Prognosis in Diffused Large B-Cell Lymphoma and Multiple Myeloma

This study examined the prognostic role of vagal nerve activity in patients with relapsed/refractory diffused large B-cell lymphoma (R/R-DLBCL) treated with chimeric antigen receptor cell therapy (CAR-T) and in patients with multiple myeloma (MM) undergoing an autologous hematopoietic cell transplan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atar, Or, Ram, Ron, Avivi, Irit, Amit, Odelia, Vitkon, Roy, Luttwak, Efrat, Bar-On, Yael, Gidron, Yori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917757/ https://www.ncbi.nlm.nih.gov/pubmed/36769556 http://dx.doi.org/10.3390/jcm12030908

Ejemplares similares

The Vagal Nerve, Inflammation, and Diabetes—A Holy Triangle
por: Sorski, Liat, et al.
Publicado: (2023)

Tone it down: Vagal nerve activity is associated with pro-inflammatory and anti-viral factors in breast cancer – An exploratory study
por: Ricon-Becker, Itay, et al.
Publicado: (2021)

Linear and non‑linear indices of vagal nerve in relation to sex and inflammation in patients with Covid‑19
por: Hunakova, Luba, et al.
Publicado: (2023)

P1543: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH HEMATOLOGICAL MALIGNANCIES THAT NEED VASOACTIVE SUPPORT – SINGLE CENTER STUDY
por: Vitkon, Roy, et al.
Publicado: (2023)

Vagal Nerve Activity and Short-Term Clinical Outcomes after Stroke: What Is Left May Not Be Right
por: Badarny, Samih, et al.
Publicado: (2023)

COVID-19 in patients with lymphoproliferative diseases during the Omicron variant surge
por: Bronstein, Yotam, et al.
Publicado: (2022)

Is There a Role for [(18)F]FDG PET-CT in Staging MALT Lymphoma?
por: Cohen, Dan, et al.
Publicado: (2022)

The Role of Extracellular Vesicles (EVs) in Chronic Graft vs. Host Disease, and the Potential Function of Placental Cell-Derived EVs as a Therapeutic Tool
por: Zavaro, Mor, et al.
Publicado: (2023)

The promising prognostic value of vagal nerve activity at the initial management of ovarian cancer
por: Cherifi, François, et al.
Publicado: (2022)

Components of metabolic syndrome in patients with multiple myeloma and smoldering multiple myeloma
por: Markus, Efrat, et al.
Publicado: (2020)

P560: IMPROVEMENT IN OVERALL AND RELAPSE FREE SURVIVAL OF AML PATIENTS OVER THE AGE OF 75 SINCE THE APPROVAL OF VENETOCLAX IN A REAL-WORLD SINGLE CENTER STUDY.
por: Moshe, Yakir, et al.
Publicado: (2023)

P942: MULTIPLE MYELOMA OLIGOSECRETORY RELAPSE- A CROSS SECTIONAL HISTORICAL COHORT STUDY
por: Vaxman, Iuliana, et al.
Publicado: (2023)

Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single center retrospective study
por: Vitkon, Roy, et al.
Publicado: (2021)

Toxicity and efficacy of chimeric antigen receptor T-cell therapy in patients with diffuse large B-cell lymphoma above the age of 70 years compared to younger patients – a matched control multicenter cohort study
por: Ram, Ron, et al.
Publicado: (2021)

Sequential therapy for patients with primary refractory acute myeloid leukemia: a historical prospective analysis of the German and Israeli experience
por: Ram, Ron, et al.
Publicado: (2019)

Low FXIII activity levels in intensive care unit hospitalized COVID-19 patients
por: Lichter, Yael, et al.
Publicado: (2021)

Real‐world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study
por: Shragai, Tamir, et al.
Publicado: (2022)

The Value of PET/CT in Detecting Bone Marrow Involvement in Patients With Follicular Lymphoma
por: Perry, Chava, et al.
Publicado: (2016)

Transcutaneous Vagal Nerve Stimulation Alone or in Combination With Radiotherapy Stimulates Lung Tumor Infiltrating Lymphocytes But Fails to Suppress Tumor Growth
por: Reijmen, Eva, et al.
Publicado: (2021)

The Role of the Vagus Nerve in Cancer Prognosis: A Systematic and a Comprehensive Review
por: De Couck, Marijke, et al.
Publicado: (2018)

Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma
por: Perry, C., et al.
Publicado: (2021)

Vagal nerve stimulator: Evolving trends
por: Ogbonnaya, Sunny, et al.
Publicado: (2013)

Vagal Nerve Stimulation for the Treatment of Autism
por: Derakhshan, Nima
Publicado: (2015)

P966: SMOLDERING MULTIPLE MYELOMA (MM) PROGRESSING TO ACTIVE MM DURING FOLLOW-UP: REDUCED BONE DISEASE AND IMPROVED PROGRESSION-FREE AND OVERALL SURVIVAL COMPARED TO DE-NOVO NEWLY DIAGNOSED MM
por: Fridberg, Gil, et al.
Publicado: (2023)

Predictors of Early and Late Mortality for Patients with Hematologic Malignancy and Invasive Mold Disease
por: Yashphe, Eva L., et al.
Publicado: (2021)

Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy—A Single-Center Prospective Cohort Study
por: Ram, Ron, et al.
Publicado: (2021)

Intraoperative nerve stimulation during vagal nerve stimulator placement
por: Kamada, Chie, et al.
Publicado: (2023)

The Vagus Nerve Can Predict and Possibly Modulate Non-Communicable Chronic Diseases: Introducing a Neuroimmunological Paradigm to Public Health
por: Gidron, Yori, et al.
Publicado: (2018)

Vagal nerve stimulation for pharmacoresistant epilepsy in children
por: Hauptman, Jason S., et al.
Publicado: (2012)

Challenging diagnosis of cervical vagal nerve schwannoma
por: Pankratjevaite, Lina, et al.
Publicado: (2022)

Application of Noninvasive Vagal Nerve Stimulation to Stress-Related Psychiatric Disorders
por: Bremner, James Douglas, et al.
Publicado: (2020)

The Relationship between a New Biomarker of Vagal Neuroimmunomodulation and Survival in Two Fatal Cancers
por: Gidron, Y., et al.
Publicado: (2018)

The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission—A retrospective multicenter study
por: Shargian, Liat, et al.
Publicado: (2022)

P571: OUTPATIENT INITIATION OF VENETOCLAX-AZACITIDINE FOR SELECTED ACUTE MYELOID LEUKEMIA PATIENTS IS FEASIBLE AND SAFE: A REAL WORLD SINGLE CENTER ANALYSIS
por: Gat, Roi, et al.
Publicado: (2023)

Vagal Nerve Stimulation Therapy: What Is Being Stimulated?
por: Kember, Guy, et al.
Publicado: (2014)

To the Editor— Treatment of asystole caused by vagal nerve stimulator
por: Antolic, Bor, et al.
Publicado: (2018)

Pharmacological Modulation of Vagal Nerve Activity in Cardiovascular Diseases
por: Liu, Longzhu, et al.
Publicado: (2018)

The prospects for poststroke neural repair with vagal nerve stimulation
por: Ward, Nick
Publicado: (2023)

Evidence of extraganglionic vagal mechanoreceptors in the mouse vagus nerve
por: Leon‐Mercado, Luis, et al.
Publicado: (2023)

Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation
por: Hodkinson, Brendan P., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oushrskparj51n9pggj3jkcfd4